Literature DB >> 8610824

Chronic PTSD in Vietnam combat veterans: course of illness and substance abuse.

J D Bremner1, S M Southwick, A Darnell, D S Charney.   

Abstract

OBJECTIVE: The purpose of this study was to measure the longitudinal course of specific symptoms of posttraumatic stress disorder (PTSD) and related symptoms of alcohol and substance abuse and the effects of alcohol and substances on the symptoms of PTSD.
METHOD: A structured interview for the assessment of PTSD and alcohol and substance abuse, as well as other factors such as life stressors and treatment, was administered to 61 Vietnam combat veterans with PTSD.
RESULTS: Onset of symptoms typically occurred at the time of exposure to combat trauma in Vietnam and increased rapidly during the first few years after the war. Symptoms plateaued within a few years after the war, following which the disorder became chronic and unremitting. Hyperarousal symptoms such as feeling on guard and feeling easily startled developed first, followed by avoidant symptoms and finally by symptoms from the intrusive cluster. The onset of alcohol and substance abuse typically was associated with the onset of symptoms of PTSD, and the increase in use paralleled the increase of symptoms. Patients reported a tendency for alcohol, marijuana, heroin, and benzodiazepines to make PTSD symptoms better, while cocaine made symptoms in the hyperarousal category worse. There was no relationship between treatment interventions and the natural course of PTSD.
CONCLUSIONS: These findings suggest that symptoms of PTSD begin soon after exposure to trauma, that hyperarousal symptoms are the first symptoms to occur, that the natural course of alcohol and substance abuse parallels that of PTSD, and that specific substances have specific effects on PTSD symptoms.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8610824     DOI: 10.1176/ajp.153.3.369

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  110 in total

Review 1.  Epidemiology and management of alcohol dependence in individuals with post-traumatic stress disorder.

Authors:  Elissa McCarthy; Ismene Petrakis
Journal:  CNS Drugs       Date:  2010-12       Impact factor: 5.749

2.  Treatment outcomes for veterans with PTSD and substance use: Impact of specific substances and achievement of abstinence.

Authors:  Ajay Manhapra; Elina Stefanovics; Robert Rosenheck
Journal:  Drug Alcohol Depend       Date:  2015-09-25       Impact factor: 4.492

Review 3.  Cannabinoid-related agents in the treatment of anxiety disorders: current knowledge and future perspectives.

Authors:  Simone Tambaro; Marco Bortolato
Journal:  Recent Pat CNS Drug Discov       Date:  2012-04-01

4.  PTSD and Cannabis-Related Coping Among Recent Veterans in New York City.

Authors:  Luther Elliott; Andrew Golub; Alexander Bennett; Honoria Guarino
Journal:  Contemp Drug Probl       Date:  2015-03-02

5.  Clinical factors associated with prescription drug use disorder in urban primary care patients with chronic pain.

Authors:  Jane M Liebschutz; Richard Saitz; Roger D Weiss; Tali Averbuch; Sonia Schwartz; Ellen C Meltzer; Elizabeth Claggett-Borne; Howard Cabral; Jeffrey H Samet
Journal:  J Pain       Date:  2010-03-24       Impact factor: 5.820

6.  The enduring effects of abuse and related adverse experiences in childhood. A convergence of evidence from neurobiology and epidemiology.

Authors:  Robert F Anda; Vincent J Felitti; J Douglas Bremner; John D Walker; Charles Whitfield; Bruce D Perry; Shanta R Dube; Wayne H Giles
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-11-29       Impact factor: 5.270

Review 7.  The endocannabinoid system as a target for novel anxiolytic drugs.

Authors:  Sachin Patel; Mathew N Hill; Joseph F Cheer; Carsten T Wotjak; Andrew Holmes
Journal:  Neurosci Biobehav Rev       Date:  2017-05       Impact factor: 8.989

Review 8.  Neuroimaging in posttraumatic stress disorder and other stress-related disorders.

Authors:  J Douglas Bremner
Journal:  Neuroimaging Clin N Am       Date:  2007-11       Impact factor: 2.264

9.  Dorsal hippocampal interleukin-1 signaling mediates heroin withdrawal-enhanced fear learning.

Authors:  Shveta V Parekh; Jacqueline E Paniccia; Christina L Lebonville; Donald T Lysle
Journal:  Psychopharmacology (Berl)       Date:  2020-08-28       Impact factor: 4.530

10.  Preliminary, open-label, pilot study of add-on oral Δ9-tetrahydrocannabinol in chronic post-traumatic stress disorder.

Authors:  Pablo Roitman; Raphael Mechoulam; Rena Cooper-Kazaz; Arieh Shalev
Journal:  Clin Drug Investig       Date:  2014-08       Impact factor: 2.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.